People: Aastrom Biosciences Inc (ASTM.O)
9 Dec 2013
Mr. Daniel R. Orlando is Chief Operating Officer, Chief Business Officer, Chief Commercial Officer of Aastrom Biosciences, Inc. He was appointed as Chief Operating Officer of the Company on August 23, 2013. Mr. Orlando has been serving as Chief Commercial Officer of the Company since August 2012 and as the Chief Business Officer of the Company since May 2013. He also served as the Company’s interim Chief Executive Officer from December 2012 to March 2013. He has more than 20 years of commercial product preparation and launch experience including leadership roles in sales, marketing and most recently as a vice president of business development for North and South America at Takeda Pharmaceuticals. As an early employee at Takeda North America, he served as the original brand director for Actos, which became the #1 branded anti-diabetic agent in the U.S. Mr. Orlando’s initial pharmaceutical experience came in progressively expanding roles in sales and marketing at Abbott Laboratories. He holds an MBA from Florida Atlantic University and a BA in economics with Honors from the University of Florida.
|Total Annual Compensation, USD||Long-Term Incentive Plans, USD||All Other, USD||Fiscal Year Total, USD|